More Proposed Acquisitions In Cannabis Decided By Shareholder Votes

4 min readPublished On: April 26th, 2021By

VANCOUVER, B.C.,– Aphria Inc (NASDAQ: APHA) (TSX: APHA) has seen its shareholders approve the proposed merger with that of Tilray Inc (NASDAQ: TLRY). Following the approval, Tilray is now one step closer to acquiring all the outstanding shares of Aphria.

The special meeting saw of those shares voted 99.38% in favour of the proposed transaction, thereby approving the merger arrangement.

Upon approval, shareholders of Aphria are to receive 0.8381 of a Tilray Class 2 common share for each share of Aphria held. Tilray shareholders meanwhile will continue to hold their current shares with no adjustments being conducted.

The closing of the arrangement remains subject to approval by Tilray shareholders as well as the courts. Tilray announced that the meeting has been pushed to April 30 at 11:00 AM to allow shareholders more time to vote. It’s unclear what specifically caused the company to delay voting. Aphria last traded at CAD$17.67 on the TSX.

IM Cannabis and MYM Nutraceuticals

Another proposed merger is getting resistance from shareholders is the IM Cannabis (NASDAQ: IMCC) (CSE: IMCC) and MYM Nutraceuticals Inc. (OTCQB: MYMMF) (CSE: MYM). MYM Nutraceuticals, a Canadian marijuana company with nationwide distribution and impressive sales growth Q1 2021 sales of CDN$1.35 million to Q2 2021 sales of CDN$4.1 million, equating to a over 200% increase from the previous quarter and pulled out CDN$845,776 in EBITDA.

The Acquisition was announced April 1, 2021 and IMCC closed at C$8.89 that day valuing the 0.022 share conversion for MYM shareholders at C$0.19558 per share, that same day MYM shares closed at CAD$0.23.

Since the announcement IMCC shares have fallen over 29% to ~CDN$6.30 and over 50% since March 3, 2021 from its high of CDN$13.00. IMCC adjusted price would put the value to MYM shareholders at just over 13 cents on April 21, 2021.


Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this publication is not provided to any individual with a view toward their individual circumstances. This report is provided by USA News Group which is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ“). Individuals are strongly encouraged to not use this publication as the basis for any investment decision.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. The owner/operator of MIQ holds no shares of Aphria Inc. or Tilray Inc., but own shares in MYM Nutraceuticals Inc., and have shorted shares of IMCC and will cover this short position at anytime hereafter. We also reserve the right to buy long, or sell short, any of the stocks mentioned herein, and will buy and/or sell shares in said companies effective immediately. Individuals should assume that all information contained in any of our reports is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

(This information is primarily sourced from USA News Group & FN Media.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here)

About the Author: News Team

Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News

CBD Kratom Heads West in New York City

December 4th, 2021|

ST. LOUIS, - CBD Kratom will open its fifth New York City store, 2039-B Broadway in the Upper West Side with a soft store opening planned for today, December 3 followed by an official Grand ...